PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31938716-1 2020 Background: Daptomycin and ceftaroline (DAP-CPT) have been used for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB), but have rarely been compared with other therapies. T 91825 27-38 death associated protein Homo sapiens 40-43 33609718-2 2021 Combination therapy with daptomycin and ceftaroline (DAP+CPT) represents a novel therapeutic approach to MRSA BSI due to synergistic bactericidal activity. T 91825 40-51 death associated protein Homo sapiens 53-56